Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Double-Blind Glycine Placebo Crossover	STARTED	Glycine, Then Placebo	1
Double-Blind Glycine Placebo Crossover	STARTED	Placebo, Then Glycine	1
Double-Blind Glycine Placebo Crossover	COMPLETED	Glycine, Then Placebo	1
Double-Blind Glycine Placebo Crossover	COMPLETED	Placebo, Then Glycine	1
Double-Blind Glycine Placebo Crossover	NOT COMPLETED	Glycine, Then Placebo	0
Double-Blind Glycine Placebo Crossover	NOT COMPLETED	Placebo, Then Glycine	0
Open-label Glycine	STARTED	Glycine, Then Placebo	1
Open-label Glycine	STARTED	Placebo, Then Glycine	1
Open-label Glycine	COMPLETED	Glycine, Then Placebo	1
Open-label Glycine	COMPLETED	Placebo, Then Glycine	1
Open-label Glycine	NOT COMPLETED	Glycine, Then Placebo	0
Open-label Glycine	NOT COMPLETED	Placebo, Then Glycine	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01720316/flow